Chief Medical Officer · Rapport Therapeutics, Inc. (RAPP)

Jeffrey Sevigny

FY2025 is the first fiscal year CompBrief holds for Jeffrey Sevigny as a named executive officer of Rapport Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$3,023,942

2nd of 3 named executive officers at Rapport Therapeutics by FY2025 total.

3 named officers on file for Rapport Therapeutics, FY2025

See an example →

What this number hides

The filing gives the total. Rapport Therapeutics’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how Rapport Therapeutics’s whole pay program stands against its peers

  • Rapport Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RAPP→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2026 (DEF 14A).

Free

Get Jeffrey Sevigny’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Jeffrey Sevigny and every company like it: Velarion Intel, free for 3 days, no card →

Jeffrey Sevigny compensation by year

Rapport Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Rapport Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$561,087
Bonus$0
Stock awards$0
Option awards$2,101,230
Non-equity incentive$283,780
Pension and deferred compensation$0
All other$77,845
Total$3,023,942

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Rapport Therapeutics, Inc. DEF 14A filed April 23, 2026, accession 0001193125-26-171828, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Rapport Therapeutics, Inc. filed document, accession 0001193125-26-171828. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option300,000—$9.56

Per the Outstanding Equity Awards at Fiscal Year-End table in Rapport Therapeutics, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Rapport Therapeutics’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Abraham CeesayChief Executive Officer and Director$6,265,174
Jeffrey Sevigny · this pageChief Medical Officer$3,023,942
Troy IgnelziChief Financial Officer$2,506,139

Jeffrey Sevigny's compensation dossier, Rapport Therapeutics

You have read Jeffrey Sevigny's totals and holdings. The dossier adds each equity grant Rapport Therapeutics disclosed for Jeffrey Sevigny and Rapport Therapeutics's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full Rapport Therapeutics compensation record

free company brief

This page is one person within Rapport Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Rapport Therapeutics's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Rapport Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order RAPP

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Jeffrey Sevigny's compensation dossier